motherlodetv.net
Bayhorse Silver Inc. (TSXV: BHS) (the “Company” or “Bayhorse”) announces, subject to TSX-Venture Exchange (TSX-V) approval, it has closed a 2nd tranche of is three year, 12%, Convertible, Silver-Convertible, Debentures (the “Debentures”) for gross proceeds of to US$465,000. Total proceeds to date from both the 1st and 2nd tranche is US$690,000.
FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce that Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) has added the Company to the Horizons Marijuana Life Sciences Index ETF (“HMMJ:TSX“) as part of the quarterly rebalance of the constituent holdings of HMMJ. The Company stock has a 1.9% weighting in HMMJ. According to Horizons ETFs, “As at September 5, 2018, HMMJ had reached over CAD $1 billion in assets under management – a rare achievement for the Canadian ETF marketplace”.1
Goldplay Exploration Ltd. (TSXV: GPLY, OTCQB: GLYXF – the “Company” or “Goldplay”) is pleased to announce additional results from sampling of the historical core drill holes, completed in 2010 (“historical core”), from the Company’s San Marcial Project in Mexico, with confirmation of attractive mineralized intervals down dip from the historic resource area and also along the mineralized trend. The results announced in this current release, together with the historical results below (from news release August 16th, 2018), reinforce open pit development potential at San Marcial:
MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: 1MG / OTCQB: MGXMF) is pleased to announce it has received notice from the Chilean state agency National Geology and Mining Service (“SERNAGEOMIN”) that the Company will be approved to carry out a 6-hole drill program at the Francisco Basin lithium project (“Francisco Basin” or the “Project”) located 30 kilometers south of Salar de Maricunga. MGX has also received a positive response from the Environmental Assessment Service (“SEA”) and does not expect that an environmental impact assessment will be required in order to carry out these exploration activities on the Project.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce multiple high grade surface samples along strike from the recent Vertigo discovery and further expanding the footprint of the high grade mineralized system. Surface grab samples were taken on the Vertigo target along trend from the recently announced discovery hole which encountered 56.25 g/t Au over 3.05m within a broader intercept of 17.34 g/t Au over 10.67m from 3.05m depth (announced September 17, 2018) as well as on the undrilled Suspicion target area 4.1km along trend from Vertigo on the Company’s JP Ross Property, Yukon Canada. The samples are interpreted as being in-place and representative of the bedrock below due to the unglaciated nature of the area. Images to accompany this news release can be found at http://whitegoldcorp.ca/investors/exploration-highlights/.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FSE: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab Therapeutics Limited (CSE: PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market. The manufacturing equipment consists of a fully GMP High output Tablet press capable of pressing more than 1,500,000 tablets per day, as well as blending machinery, large scale process and drying equipment and packaging equipment.
Advantage Lithium Corp. (the “Corporation” or “Advantage Lithium”) (TSX Venture: AAL) (OTCQX: AVLIF) is pleased to announce the filing on SEDAR of its Preliminary Economic Assessment (“PEA”) Report following summary results announced on August 14, 2018.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that the Company has received its first delivery of manufacturing equipment at its Cobourg plant from Canntab Therapeutics Limited (CSE:PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market. The manufacturing equipment consists of a fully GMP High output Tablet press capable of pressing more than 1,500,000 tablets per day, as well as blending machinery, large scale process and drying equipment and packaging equipment.
Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) announces that additional analytical results have been received from the early-stage drilling at the 23,000 hectare Forrest Kerr Property (the “Property”) located in the Golden Triangle region of British Columbia. The eight drill holes reported here consist of step-out drilling at the North Boundary Zone and most of the holes intersected shallow, high-grade gold mineralization. Highlights include: 5.08 g/t Au over 12.0m in hole FK18-12; 23.3 g/t Au over 2.0m in hole FK18-13; and 10.62 g/t Au over 3.0m in hole FK18-17. To date, final analytical results have been received for 3,000m of a total projected 10,000m (table of values and hole descriptions near end of release).
Bayhorse Silver Inc. (TSXV: BHS) (The “Company” or “Bayhorse”) is pleased to announce the release of a Maiden Inferred Mineral Resource for the 100% controlled Bayhorse Silver Mine, Oregon, USA. The maiden resource is comprised of 292,300 short tons at an average grade of 21.65 troy ounces per ton (opt) silver (Ag) for total contained silver of 6,328,400 ounces. The mineralized material contains significant amounts of copper (Cu) and zinc (Zn), however the historic data utilized in the mineral resource estimate did not allow for a reliable calculation of the grade of Cu and Zn.